Liver transplantation in HIV-HCV coinfected patients: A case-control study

Transplantation

Volumn 83, Issue 3, 2007, Pages 354-358

  Castells, Lluis ^a   Escartín, Alfredo ^a   Bilbao, Itxarone ^a   Len, Oscar ^a   Allende, Helena ^a   Vargas, Víctor ^a   Ribera, Esteban ^a   Lázaro, José Luis ^a   Bueno, Javier ^a   Balsells, Joaquin ^a   Esteban, Rafael ^a   Pahissa, Albert ^a   Margarit, Carlos ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Antiviral treatment; HAART toxicity; HCV infection; HCV recurrence; HIV infection; Liver transplantation

Indexed keywords

ABACAVIR; BASILIXIMAB; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON; RIBAVIRIN; STEROID; TACROLIMUS; TENOFOVIR; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MONOTHERAPY; PRIORITY JOURNAL; SURVIVAL RATE; VIROLOGY;

ADULT; AGED; ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; STEROIDS; TACROLIMUS; TREATMENT OUTCOME;

EID: 33846958018     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000251378.70853.90     Document Type: Article

References (21)

1. Ragni MV, Belle SH, Im K, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infec Dis 2003; 188: 1405.
2. Neff GW, Bonham A, Tzakis AG, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003; 9: 239.
3. Rafecas A, Rufi G, Figueras J, et al. Liver transplantation without steroid induction in HIV-infected patients. Liver Transpl 2004; 10: 1320.
4. Vogel M, Voigt E, Michaelis HC, et al. Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ ritonavir in liver-transplanted HIV-infected patients. Liver Transpl 2004; 10: 939.
5. Prachalias AAQ, Pozniak A, Taylor C, et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72: 1684.
6. Norris S, Taylor C, Muiesan P, et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl 2004; 10: 1271.
7. Moreno S, Fortun J, Quereda C, et al. Liver transplantation in HIVinfected recipients. Liver Transpl 2005; 11: 76.
8. Duclos-Valle'e J, Feray C, Roque-Afonso AM, et al. Recurrence of hepatitis C virus is more severe in liver transplanted HIV-HCV coinfected patients than in HCV mono-infected patients. Liver Transpl 2005; 11: C3.
9. Duclos-Vallee JC, Vittecoq D, Teicher E, et al. Hepatitis C virus viral recurrence and liver mitochondrial damage alter liver transplantation in HIV-HCV co-infected patients. J Hepatol 2005; 42: 341.
10. Radecke K, Fruhauf NR, Miller M, et al. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitisinduced cirrhosis. Liver Int 2005; 25: 101.
11. Miro JM, Torre-Cisnero J, Moreno A, et al. GESIDA/GESITRASEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain. Enferm Infecc Microbiol Clin 2005; 23: 353.
12. Paterson DL, Singh N. Interactions between tacrolimus and antimicrobial agents. Clin Infect Dis 1997; 25: 1430.
13. Izzedine H, Launay-Vacher V, Baumelou A, Deray G. Antiretroviral and immunosuppressive drug-drug interactions: an update. Kidney Int 2004; 66: 532.
14. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002-June 10-12, 2002. Hepatology 2002; 36: S3.
15. Lafeuillade A, Hittinger G, Chadapaud S. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection. Lancet 2001; 357: 280.
16. Antoniades C, Macdonald C, Knisely A, et al. Mitochondrial toxicity associated with HAART following liver transplantation in an HIVinfected recipient. Liver Transpl 2004; 10: 699.
17. Gordon FP, Pomfret EA, Pomposelli JJ, et al. Severe steatosis as the initial histologic manifestation of recurrent hepatitis C genotype 3. Hum Pathol 2004; 35: 636.
18. Margarit C, Bilbao I, Castells LL, et al. A prospective randomised trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: impact on recurrence of hepatitis C. Transpl Int 2005; 18: 1336.
19. Samuel D, Duclos Vallee JC, Teicher E, Vittecoq D. Liver transplantation in patients with HIV infection. J Hepatol 2003; 39: 3.
20. Forman LM, Lewis JD, Berlin JA, et al. The association between hepatitisCinfection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889.
21. Castells LL, Vargas V, Allende H, et al. Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of HCV recurrence after liver transplantation. J Hepatol 2005; 43: 53.